ArticleActa pharmacologica Sinica2025

MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism.

Li-da Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.